PRODUCT DETAIL

Erlotinib Vipharm 150 mg

Code

2275D

MA number

44/0251/19-S

Product Form:

tbl flm 30x150 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Mutual recognition procedure

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EB	Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB02	Erlotinib

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	07.08.2019
SPC:	SPC_Erlotinib Vipharm 150 mg_10.2023.pdf
PIL:	PIL_Erlotinib Vipharm 150 mg_10.2023.pdf
Safety feature	Yes
Data update:	13.12.2023